Diabetes Mellitus, Non-Insulin-Dependent
GPTKB entity
Statements (52)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:disease
|
gptkbp:abbreviation |
gptkb:T2DM
|
gptkbp:affects |
glucose metabolism
|
gptkbp:alsoKnownAs |
gptkb:Type_2_Diabetes_Mellitus
|
gptkbp:associatedWith |
gptkb:metabolic_syndrome
|
gptkbp:cause |
myocardial infarction
stroke chronic kidney disease vision loss amputation peripheral artery disease |
gptkbp:characterizedBy |
insulin resistance
relative insulin deficiency |
gptkbp:complication |
gptkb:cardiovascular_disease
gptkb:nephropathy peripheral neuropathy retinopathy foot ulcers |
gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting plasma glucose |
gptkbp:firstDescribed |
20th century
|
https://www.w3.org/2000/01/rdf-schema#label |
Diabetes Mellitus, Non-Insulin-Dependent
|
gptkbp:ICD-10_code |
E11
|
gptkbp:managedBy |
gptkb:food
gptkb:drug exercise weight loss |
gptkbp:onset |
adulthood
|
gptkbp:prevalence |
high worldwide
|
gptkbp:riskFactor |
age
family history obesity hypertension sedentary lifestyle dyslipidemia |
gptkbp:subspecies |
Latent Autoimmune Diabetes in Adults (LADA)
Maturity Onset Diabetes of the Young (MODY) |
gptkbp:symptom |
fatigue
blurred vision polydipsia polyuria |
gptkbp:treatment |
gptkb:metformin
gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents sulfonylureas insulin (in advanced cases) |
gptkbp:bfsParent |
gptkb:D004053
gptkb:D004481 |
gptkbp:bfsLayer |
7
|